Press-release for stocks for sanofi

entities : Sanofi

save search

Concerto Biosciences Announces Strategic Business Development Hire
Published: 2023-02-06 (Crawled : 14:00) - biospace.com/
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| -0.91% | O: -0.84% H: 0.0% C: 0.0%

Scholar Rock Appoints Tracey M. Sacco as Chief Commercial Officer
Published: 2023-02-06 (Crawled : 14:00) - biospace.com/
SRRK A | $13.96 1.9% 1.86% 860K

Health Technology

| 9.86% | O: -1.12% H: 0.93% C: -0.08%
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| -0.91% | O: -0.84% H: 0.0% C: 0.0%
commercial rock

Health Equity Report Card Pilot Project to Help Close the Care Gap Highlighted on World Cancer Day
Published: 2023-02-04 (Crawled : 16:20) - prnewswire.com
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| Email alert Add to watchlist
SNYNF | News | $92.7 -2.18% 1.4K

Health Technology

| Email alert Add to watchlist
ABBV | News | $164.66 0.25% -0.15% 4.5M

Health Technology

| Email alert Add to watchlist
day care report health pilot cancer

Sanofi Admits Defeat for Myasthenia Gravis Candidate, Drops Phase III Trial
Published: 2023-02-03 (Crawled : 16:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K

Health Technology

| -5.94% | O: -5.75% H: 0.0% C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| -4.89% | O: -4.01% H: 0.0% C: 0.0%
trial sanofi

Regeneron Reports Fourth Quarter and Full Year 2022 Financial and Operating Results
Published: 2023-02-03 (Crawled : 12:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 1.4K

Health Technology

| -5.94% | O: -5.75% H: 0.0% C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| -4.89% | O: -4.01% H: 0.0% C: 0.0%
REGN | $893.66 -0.84% -0.84% 450K

Health Technology

| 19.97% | O: 1.77% H: 3.33% C: 2.44%
CTMX | $1.735 -1.42% -1.44% 200K

Health Technology

| -28.19% | O: 0.39% H: 4.23% C: 1.92%
ACET | $2.02 -11.01% -12.38% 930K

Health Technology

| -75.41% | O: -1.63% H: 1.98% C: -3.52%
year financial results

Press Release : Strong sales performance and double digit EPS growth marking the achievement of the 2022 profitability milestone
Published: 2023-02-03 (Crawled : 07:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 1.4K

Health Technology

| -5.94% | O: -5.75% H: 0.0% C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| -4.89% | O: -4.01% H: 0.0% C: 0.0%
sales growth milestone

The Worldwide OTC Hyaluronic Acid Industry is Expected to Reach $6.2 Billion by 2027: Adoption of Nonsurgical Cosmetic Procedures Drives Growth
Published: 2023-02-02 (Crawled : 20:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K

Health Technology

| -5.94% | O: -5.75% H: 0.0% C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| -4.89% | O: -4.01% H: 0.0% C: 0.0%
expected growth

The Global Antiviral Drugs Market to Exhibit Growth at a Paltry CAGR of ~4% by 2027 | DelveInsight
Published: 2023-02-02 (Crawled : 16:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K

Health Technology

| 28.31% | O: -1.71% H: 0.0% C: 0.0%
VTRS | $11.11 0.09% 0.09% 3.5M

Health Technology

| -9.3% | O: -0.16% H: 0.08% C: -0.41%
NVS | $92.57 -0.55% 0.0% 910K

Health Technology

| 5.5% | O: -1.87% H: 0.01% C: -0.55%
JNJ | News | $145.74 0.67% 0.0% 9.3M

Health Technology

| -12.11% | O: -1.16% H: 1.98% C: 1.56%
BMY | $48.3 0.96% 0.33% 8.9M

Health Technology

| -32.19% | O: -1.28% H: 3.64% C: 3.48%
ABBV | News | $164.66 0.25% -0.15% 4.5M

Health Technology

| 12.66% | O: -0.46% H: 0.0% C: -0.75%
VIR | $7.96 -3.52% -3.64% 880K

Health Technology

| -71.71% | O: 0.62% H: 2.22% C: 1.94%
TNXP | $0.1549 -2.82% -2.91% 1.4M

Health Technology

| -97.81% | O: 0.85% H: 5.08% C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| -6.26% | O: -1.44% H: 0.0% C: 0.0%
GILD | News | $66.16 -1.15% -1.16% 6.4M

Health Technology

| -20.36% | O: -1.95% H: 0.16% C: -1.18%
global antiviral growth market

Merck Announces Fourth-Quarter and Full-Year 2022 Financial Results
Published: 2023-02-02 (Crawled : 14:00) - biospace.com/
ALPMY | $9.46 -1.11% 500K

Manufacturing

| -36.68% | O: 1.22% H: 0.0% C: -1.61%
MRK | $125.23 -0.11% -0.54% 3.4M

Health Technology

| 17.19% | O: -2.77% H: 1.72% C: -0.54%
SGEN | $228.74 0.1% 20M

Health Technology

| 64.53% | O: -0.37% H: 1.07% C: 0.66%
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| -6.26% | O: -1.44% H: 0.0% C: 0.0%
MRNA S | $102.015 -1.38% -1.4% 1.7M

Health Technology

| -40.65% | O: -0.52% H: 1.92% C: 1.7%
financial results

IGM Biosciences to Present at the Guggenheim 2023 Oncology Conference
Published: 2023-02-02 (Crawled : 13:20) - biospace.com/
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| -6.26% | O: -1.44% H: 0.0% C: 0.0%
IGMS | $7.4 -8.98% -9.86% 450K

Health Technology

| -68.01% | O: 3.07% H: 6.95% C: 6.41%
conference

MoonLake Immunotherapeutics completes patient enrollment and randomization ahead of schedule in a Phase 2 trial of the Nanobody® sonelokimab in moderate-to-severe hidradenitis suppurativa
Published: 2023-02-02 (Crawled : 13:20) - globenewswire.com
MLTX | $42.31 -2.76% -2.84% 230K

| 256.35% | O: 0.33% H: 1.71% C: -1.63%
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| -6.26% | O: -1.44% H: 0.0% C: 0.0%
nanobody trial

BioNTech Strengthens Manufacturing Capabilities with First In-House Plasmid DNA Manufacturing Facility
Published: 2023-02-02 (Crawled : 12:00) - globenewswire.com
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| -6.26% | O: -1.44% H: 0.0% C: 0.0%
BNTX | $86.19 -0.24% -0.24% 580K

Health Technology

| -39.76% | O: -0.29% H: 1.63% C: 1.23%
dna

Frazier Life Sciences Adds Highly Experienced T Cell Immunologist to Team
Published: 2023-02-01 (Crawled : 14:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K

Health Technology